Stock GE9 GENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Genmab A/S Deutsche Boerse AG

Equities

GE9

DK0010272202

Market Closed - Deutsche Boerse AG
Other stock markets
 01:11:05 29/06/2024 am IST 		5-day change 1st Jan Change
232.7 EUR -1.90% Intraday chart for Genmab A/S -4.24% -19.03%
28/06 Would you like some more inflation? Our Logo
28/06 Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU MT

Chart calendar Genmab A/S

1.4Ft1XBA21q_awQgeNeD3_NJM2tdZ1sJAG-cKOMwyWRg.mj0_BClelN-V9kZZQoq4sKMElZYxhfMlfaVFDahZGEyxFQIWKEODy573WQ~d11f0ed41d4a4ba47dfcb8695a786564

Upcoming events on Genmab A/S

01/08/2024 08:30 pm Q2 2024 Earnings Release
06/11/2024 09:30 pm Q3 2024 Earnings Release
19/02/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)
06/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Genmab A/S

15/06/2024 08:00 pm European Hematology Association Meeting - Abstract Number :S234
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1244
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1133
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1140
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1121
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1114
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1161
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1152
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1151
14/06/2024 09:30 pm European Hematology Association Meeting - Abstract Number :P1146
14/06/2024 06:15 pm European Hematology Association Meeting - Abstract Number :S239
14/06/2024 06:15 pm European Hematology Association Meeting - Abstract Number :S163
14/06/2024 12:30 pm European Hematology Association Meeting - Abstract Number :P2059
14/06/2024 12:30 pm European Hematology Association Meeting - Abstract Number :P2081
14/06/2024 12:30 pm European Hematology Association Meeting - Abstract Number :PB2955
14/06/2024 12:30 pm European Hematology Association Meeting - Abstract Number :P2060
10/06/2024 06:50 pm Goldman Sachs Global Healthcare Conference
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No:TPS7084
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No:7039
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No:7037

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million DKK		Released
Forecast
Spread 		5 366
5 159
4.02%		10 111
9 843
2.72%		8 482
8 376
1.26%		14 595
14 068
3.75%		16 474
16 380
0.58%
19 804

EBITDA
Million DKK		Released
Forecast
Spread 		2 777
2 460
12.89%		6 572
6 099
7.75%		3 266
3 111
4.98%		6 719
6 371
5.46%		5 616
5 721
-1.83%
6 324

EBIT
Million DKK		Released
Forecast
Spread 		2 638
2 317
13.83%		6 313
5 967
5.79%		3 018
2 960
1.96%		6 357
6 008
5.81%		5 321
5 398
-1.42%
5 930

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		2 859
2 645
8.11%		5 904
5 723
3.17%		3 983
3 731
6.77%		7 035
8 905
-21%		5 637
6 236
-9.6%
5 853

Net income
Million DKK		Released
Forecast
Spread 		2 166
2 085
3.89%		4 758
4 706
1.1%		3 008
2 847
5.64%		5 522
6 793
-18.71%		4 352
4 989
-12.77%
4 667

EPS
DKK		Released
Forecast
Spread 		34,0
32,8
3.61%		72,2
69,4
4.06%		45,5
43,8
3.94%		83,7
104
-19.22%		66,0
76,2
-13.35%
71,9

Announcement Date19/02/2023/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1
Net sales
Million DKK		Released
Forecast
Spread 		6 343
6 164
2.9%		3 553
3 224
10.2%		2 619
2 538
3.19%		2 119
2 074
2.15%		3 162
2 833
11.6%		5 281
5 136
2.82%		4 087
3 634
12.46%		5 227
4 727
10.57%		2 854
2 809
1.62%		4 198
4 070
3.13%		7 052
6 896
2.26%		4 744
4 474
6.03%		4 678
4 610
1.48%		4 143
3 978
4.15%
4 990


9 039


5 285


5 538


5 236

EBITDA
Million DKK		Released
Forecast
Spread 		4 583
4 480
2.3%		1 345
980
37.24%		1 016
776
30.87%		529
358
47.73%		1 263
1 312
-3.74%		1 792
1 951
-8.15%		1 953
1 583
23.36%		2 974
2 708
9.84%		458
583
-21.48%		1 520
1 670
-8.96%		1 978
2 145
-7.79%		1 739
1 646
5.65%		1 899
1 804
5.28%		823
882
-6.66%
1 508


2 412


1 712


2 045


2 850

EBIT
Million DKK		Released
Forecast
Spread 		4 568
4 389
4.08%		1 319
864
52.66%		809
772
4.76%		514
442
16.3%		1 247
1 156
7.87%		1 761
1 814
-2.92%		1 931
1 541
25.34%		2 665
2 314
15.17%		437
527
-17.08%		1 497
1 573
-4.85%		1 934
1 977
-2.18%		1 717
1 702
0.87%		1 670
1 772
-5.73%		801
788
1.64%
390


2 229


1 632


1 819


1 547

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		4 682
4 682
0%		1 846
1 759
4.95%		966
772
25.06%		612
499
22.59%		2 489
1 183
110.39%		3 101
1 932
60.51%		3 272
1 584
106.63%		662
2 199
-69.9%		286
402
-28.85%		1 723
1 602
7.57%		2 009
1 927
4.26%		2 702
1 774
52.33%		926
1 888
-50.95%		1 716
921
86.25%
199


3 374


1 714


1 687


1 634

Net income
Million DKK		Released
Forecast
Spread 		3 647
4 573
-20.25%		1 402
1 372
2.19%		716
603
18.69%		465
357
30.19%		1 891
913
107.1%		2 356
1 469
60.38%		2 582
1 187
117.46%		584
1 556
-62.47%		226
397
-43.08%		1 357
1 204
12.72%		1 583
1 503
5.32%		2 129
1 382
54.01%		640
1 439
-55.52%		1 325
779
70.01%
463


2 598


1 371


1 274


1 280

EPS
DKK		Released
Forecast
Spread 		55,5
70,2
-20.91%		21,3
20,9
1.67%		10,8
9,25
16.99%		7,05
5,39
30.88%		28,7
13,8
106.99%		35,7
22,1
61.58%		39,2
18,3
113.88%		8,82
23,2
-61.91%		3,43
5,07
-32.28%		20,6
19,3
7.03%		24,0
22,7
5.86%		32,3
21,2
52.42%		9,67
23,0
-57.93%		20,2
10,6
90.39%
2,98


39,5


19,5


20,7


21,1

Announcement Date12/08/2011/08/2116/02/2211/05/2210/08/2210/08/2209/11/2222/02/2310/05/2303/08/2303/08/2307/11/2314/02/2402/05/24-----

Upcoming sector events for Genmab A/S

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Genmab A/S

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. GE9 Stock
  5. Calendar Genmab A/S